Abivax 2021 Financial Communication Calendar

DGAP-News: ABIVAX / Key word(s): Miscellaneous
03.12.2020 / 18:00
The issuer is solely responsible for the content of this announcement.

Abivax 2021 Financial Communication Calendar

PARIS, FRANCE, December 3, 2020 - 6:00 p.m. (CET) - Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, today publishes its 2021 financial communication calendar.

• Thursday, April 1, 2021
  Publication of financial statements as of December 31, 2020
   
• Friday, April 30, 2021
  Publication and release of the 2020 annual financial report
   
• Friday, June 4, 2021 - 10.00 a.m.
  Shareholders meeting
   
• Thursday, September 23, 2021
  Publication of financial statements as of June 30, 2021
   
• Thursday, September 30, 2021
  Publication and release of 2021 half year report

About Abivax (www.abivax.com)
Abivax, a clinical stage biotechnology company, is mobilizing the body's natural immune machinery to treat patients with chronic inflammatory diseases, viral infections, and cancer. Abivax is listed on Euronext compartment C (ISIN: FR0012333284 - Mnémo: ABVX). Based in Paris and Montpellier, Abivax has two drug candidates in clinical development, ABX464 to treat severe inflammatory diseases, and ABX196 to treat hepatocellular carcinoma. More information on the company is available at www.abivax.com. Follow us on Twitter @ABIVAX_.

Contacts

03.12.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de